TheEdgeResearch
Home / Stocks / CBDD

CBD of Denver, Inc. (CBDD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$1.1M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-8.71
52-Wk Range
0.0001-0.0002
CEO
Jan Schwager
Country
US
Currency
USD

CBD of Denver, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Centennial, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1.1M. On trailing twelve-month figures it carries a trailing P/E of -20.25, a net margin of -9.0%. Its beta of -8.71 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-20.25
Price / Sales
1.82
Price / Book
-0.80
EV / EBITDA
-177.20
Gross margin
5.7%
Operating margin
-2.0%
Net margin
-9.0%
Return on equity
Debt / equity
-0.73
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
1996-05-15
Headquarters
Centennial, CO, US
About CBD of Denver, Inc.

CBD of Denver, Inc. engages in the cultivation, production, and distribution of cannabis flower and CBD products in Switzerland, Europe, and the US. Its brands include CBD Social Network, Black Peal CBD, and Rockflowr. The company was founded in 1993 and is headquartered in Centennial, CO.

Comparable companies

CBD of Denver, Inc. is most often compared with the following Healthcare names:

AGRSAUNMDHHXFELEKFBCDGMBLJMIHMCOMMWWCSTHI
More research on CBDD
CBDD technical analysis CBDD TheEdge Score Compare against peers
Open full interactive analysis & DCF →